Report Detail
Global (United States, European Union and China) Endometriosis Market Research Report 2019-2025
- RnM3689933 |
- 22 August, 2019 |
- Global |
- 121 Pages |
- QYResearch |
- Pharma & Healthcare
Endometriosis is a medical condition in which the tissue that forms normal lining of uterus appears outside the uterus cavity and may involve ovaries, bowel or tissue lining of the pelvic floor.
Rising incidences of endometriosis due to diagnostic improvements leading to early identification, environmental factors, and rising awareness is the key factor contributing to growth of the market. Global endometriosis market is expected to register a healthy growth, owing to rise in awareness amongst patients and physicians. In addition, considerable research efforts towards development of novel non hormonal drugs, diagnostic and surgical techniques coupled with substantial support in terms of funding has helped to further enhance the growth of this market. Therefore, huge unmet needs for curative treatment of endometriosis will serve this market as a potential opportunity. The growth in global endometriosis market will be primarily driven by emerging Asian economies, where the disease prevalence is almost 10% of the total female population of this region.
In 2019, the market size of Endometriosis is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Endometriosis.
This report studies the global market size of Endometriosis, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Endometriosis sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
AbbVie
AstraZeneca
Bayer HealthCare
Pfizer
Addex Therapeutics
Astellas Pharma
Debiopharm
ElexoPharm
EndoCeutics
Euroscreen
Forendo Pharma
Kissei Pharmaceutical
Neurocrine Biosciences
Nippon Shinyaku
Takeda
Bayer AG
Neurocrine Biosciences
Market Segment by Product Type
Gonadotropins Releasing Hormone Agonists
Non-Steroidal Anti-Inflammatory Drugs
Progestin
Oral Contraceptive Pills
Market Segment by Application
Hospital Use
Clinic Use
Other
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Endometriosis status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Endometriosis manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Endometriosis are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Endometriosis Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Gonadotropins Releasing Hormone Agonists
- 1.3.3 Non-Steroidal Anti-Inflammatory Drugs
- 1.3.4 Progestin
- 1.3.5 Oral Contraceptive Pills
- 1.4 Market Segment by Application
- 1.4.1 Global Endometriosis Market Share by Application (2019-2025)
- 1.4.2 Hospital Use
- 1.4.3 Clinic Use
- 1.4.4 Other
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Endometriosis Market Size
- 2.1.1 Global Endometriosis Revenue 2014-2025
- 2.1.2 Global Endometriosis Sales 2014-2025
- 2.2 Endometriosis Growth Rate by Regions
- 2.2.1 Global Endometriosis Sales by Regions 2014-2019
- 2.2.2 Global Endometriosis Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Endometriosis Sales by Manufacturers
- 3.1.1 Endometriosis Sales by Manufacturers 2014-2019
- 3.1.2 Endometriosis Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Endometriosis Revenue by Manufacturers (2014-2019)
- 3.2.2 Endometriosis Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Endometriosis Market Concentration Ratio (CR5 and HHI)
- 3.3 Endometriosis Price by Manufacturers
- 3.4 Key Manufacturers Endometriosis Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Endometriosis Market
- 3.6 Key Manufacturers Endometriosis Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Gonadotropins Releasing Hormone Agonists Sales and Revenue (2014-2019)
- 4.1.2 Non-Steroidal Anti-Inflammatory Drugs Sales and Revenue (2014-2019)
- 4.1.3 Progestin Sales and Revenue (2014-2019)
- 4.1.4 Oral Contraceptive Pills Sales and Revenue (2014-2019)
- 4.2 Global Endometriosis Sales Market Share by Type
- 4.3 Global Endometriosis Revenue Market Share by Type
- 4.4 Endometriosis Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Endometriosis Sales by Application
6 United States
- 6.1 United States Endometriosis Breakdown Data by Company
- 6.2 United States Endometriosis Breakdown Data by Type
- 6.3 United States Endometriosis Breakdown Data by Application
7 European Union
- 7.1 European Union Endometriosis Breakdown Data by Company
- 7.2 European Union Endometriosis Breakdown Data by Type
- 7.3 European Union Endometriosis Breakdown Data by Application
8 China
- 8.1 China Endometriosis Breakdown Data by Company
- 8.2 China Endometriosis Breakdown Data by Type
- 8.3 China Endometriosis Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Endometriosis Breakdown Data by Company
- 9.2 Rest of World Endometriosis Breakdown Data by Type
- 9.3 Rest of World Endometriosis Breakdown Data by Application
- 9.4 Rest of World Endometriosis Breakdown Data by Countries
- 9.4.1 Rest of World Endometriosis Sales by Countries
- 9.4.2 Rest of World Endometriosis Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 AbbVie
- 10.1.1 AbbVie Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Endometriosis
- 10.1.4 Endometriosis Product Introduction
- 10.1.5 AbbVie Recent Development
- 10.2 AstraZeneca
- 10.2.1 AstraZeneca Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Endometriosis
- 10.2.4 Endometriosis Product Introduction
- 10.2.5 AstraZeneca Recent Development
- 10.3 Bayer HealthCare
- 10.3.1 Bayer HealthCare Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Endometriosis
- 10.3.4 Endometriosis Product Introduction
- 10.3.5 Bayer HealthCare Recent Development
- 10.4 Pfizer
- 10.4.1 Pfizer Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Endometriosis
- 10.4.4 Endometriosis Product Introduction
- 10.4.5 Pfizer Recent Development
- 10.5 Addex Therapeutics
- 10.5.1 Addex Therapeutics Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Endometriosis
- 10.5.4 Endometriosis Product Introduction
- 10.5.5 Addex Therapeutics Recent Development
- 10.6 Astellas Pharma
- 10.6.1 Astellas Pharma Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Endometriosis
- 10.6.4 Endometriosis Product Introduction
- 10.6.5 Astellas Pharma Recent Development
- 10.7 Debiopharm
- 10.7.1 Debiopharm Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Endometriosis
- 10.7.4 Endometriosis Product Introduction
- 10.7.5 Debiopharm Recent Development
- 10.8 ElexoPharm
- 10.8.1 ElexoPharm Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Endometriosis
- 10.8.4 Endometriosis Product Introduction
- 10.8.5 ElexoPharm Recent Development
- 10.9 EndoCeutics
- 10.9.1 EndoCeutics Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Endometriosis
- 10.9.4 Endometriosis Product Introduction
- 10.9.5 EndoCeutics Recent Development
- 10.10 Euroscreen
- 10.10.1 Euroscreen Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Endometriosis
- 10.10.4 Endometriosis Product Introduction
- 10.10.5 Euroscreen Recent Development
- 10.11 Forendo Pharma
- 10.12 Kissei Pharmaceutical
- 10.13 Neurocrine Biosciences
- 10.14 Nippon Shinyaku
- 10.15 Takeda
- 10.16 Bayer AG
- 10.17 Neurocrine Biosciences
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Endometriosis Sales Channels
- 11.2.2 Endometriosis Distributors
- 11.3 Endometriosis Customers
12 Market Forecast
- 12.1 Global Endometriosis Sales and Revenue Forecast 2019-2025
- 12.2 Global Endometriosis Sales Forecast by Type
- 12.3 Global Endometriosis Sales Forecast by Application
- 12.4 Endometriosis Forecast by Regions
- 12.4.1 Global Endometriosis Sales Forecast by Regions 2019-2025
- 12.4.2 Global Endometriosis Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Endometriosis. Industry analysis & Market Report on Endometriosis is a syndicated market report, published as Global (United States, European Union and China) Endometriosis Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Endometriosis market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
